EX-99.1 2 exhibit99-1.htm
EXHIBIT A

JOINT FILING AGREEMENT
Petros Pharmaceuticals, Inc.
 
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby confirm the agreement by and among them to the joint filing on behalf of them of the Statement on Schedule 13D and any and all further amendments thereto, with respect to the securities of the above referenced issuer, and that this Agreement be included as an Exhibit to such filing.  This Agreement may be executed in any number of counterparts each of which shall be deemed to be an original and all of which together shall be deemed to constitute one and the same Agreement.
 
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of December 11, 2020.

 
 
John D. Shulman
 
 
 
 
 
/s/ John D. Shulman
 
 
 
 
 
Metuchen Therapeutics, LLC
 
 
 
 
By:
/s/ John D. Shulman
 
 
its managing member


 
METP Holdings, LLC
   
 
       By: Juggernaut Partners III GP, L.P.,
 
               its general partner
   
 
                By: Juggernaut Partners III GP, Ltd.
 
                       its general partner
   
 
                        By:        /s/ John D. Shulman
 
                        Name:   John D. Shulman
                        Title:     Director

 
 
JCP III SM AIV, L.P.
 
 
 
 
By:
Juggernaut Partners III GP, L.P.,
   
its general partner
 
 

By: Juggernaut Partners III GP, Ltd.
its general partner
 
 
 
 
 
By:
/s/ John D. Shulman
 
 
Name:
John D. Shulman
 
 
Title:
Director
 
 
 

 
Juggernaut Partners III GP, L.P.
 
 
 
 
By:
Juggernaut Partners III GP, Ltd.
 
 
its general partner
 
 
 
 
 
 
By:
/s/ John D. Shulman
 
 
Name:
John D. Shulman
 
 
Title:
Director
 
 
 

 
Juggernaut Partners III GP, Ltd.
 
 
 
 
By:
/s/ John D. Shulman
 
Name:
John D. Shulman
 
Title:
Director